STUDY SEARCH RESULTS

1 study found for your search request:  7339-001

Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) f...
Condition: Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms
Minimum Age: 18 years, Maximum Age: N/A
Gender: Female
Study ID: NCT03740165
Status: Active, not recruiting




Copyright © 2024 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  U.S. Corporate Site